Antitumor activity of TAK-441 involves inhibition of zinc finger protein GLI1 expression April 8, 2011
Multiple studies of hepatitis C treatment telaprevir presented at International Liver Congress April 8, 2011
AXL-1717 exhibits safety/tolerability in subjects with advanced tumors in phase I/II trial April 8, 2011
New farnesoid X receptor agonist Px-20606 prevents nonalcoholic steatohepatitis in an animal model April 8, 2011
Progenra's ubiquitin carboxyl-terminal hydrolase inhibitors show preclinical antitumor activity April 8, 2011
RSS